Literature DB >> 18694679

Antibiotic prophylaxis in dermatologic surgery: advisory statement 2008.

Tina I Wright1, Larry M Baddour, Elie F Berbari, Randall K Roenigk, P Kim Phillips, M Amanda Jacobs, Clark C Otley.   

Abstract

BACKGROUND: Antibiotic prophylaxis is an important component of dermatologic surgery, and recommendations in this area should reflect the updated 2007 guidelines of the American Heart Association, the American Dental Association with the American Academy of Orthopaedic Surgeons guidelines, and recent prospective studies on surgical site infection.
OBJECTIVE: To provide an update on the indications for antibiotic prophylaxis in dermatologic surgery for the prevention of infective endocarditis, hematogenous total joint infection, and surgical site infection.
METHODS: A literature review was performed, expert consensus was obtained, and updated recommendations were created, consistent with the most current authoritative guidelines from the American Heart Association and the American Dental Association with the American Academy of Orthopaedic Surgeons.
RESULTS: For patients with high-risk cardiac conditions, and a defined group of patients with prosthetic joints at high risk for hematogenous total joint infection, prophylactic antibiotics are recommended when the surgical site is infected or when the procedure involves breach of the oral mucosa. For the prevention of surgical site infections, antibiotics may be indicated for procedures on the lower extremities or groin, for wedge excisions of the lip and ear, skin flaps on the nose, skin grafts, and for patients with extensive inflammatory skin disease. LIMITATIONS: These recommendations are not based on multiple, large-scale, prospective trials.
CONCLUSIONS: There is a strong shift away from administration of prophylactic antibiotics in many dermatologic surgery settings, based on updated authoritative guidelines. These recommendations provide guidance to comply with the most current guidelines, modified to address dermatology-specific considerations. Managing physicians may utilize these guidelines while individualizing their approach based on all clinical considerations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18694679     DOI: 10.1016/j.jaad.2008.04.031

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  24 in total

1.  [Antibiotic prophylaxis in dermatologic and soft tissue surgery].

Authors:  T Schulze; M Napp; S Maier
Journal:  Hautarzt       Date:  2014-01       Impact factor: 0.751

2.  Infective endocarditis: rationale for revised guidelines for antibiotic prophylaxis.

Authors:  Prabhakaran P Gopalakrishnan; Sanjay K Shukla; Tahir Tak
Journal:  Clin Med Res       Date:  2009-07-16

Review 3.  Guideline for Antimicrobial Prophylaxis in Breast Surgery.

Authors:  Sema Bağhaki; Gürsel Remzi Soybir; Atilla Soran
Journal:  J Breast Health       Date:  2014-04-01

Review 4.  [Perioperative antibiotic prophylaxis in dermatosurgery-2019 status quo].

Authors:  J Lammer; A Böhner; T Volz
Journal:  Hautarzt       Date:  2019-11       Impact factor: 0.751

5.  Status Report from the Scientific Panel on Antibiotic Use in Dermatology of the American Acne and Rosacea Society: Part 3: Current Perspectives on Skin and Soft Tissue Infections with Emphasis on Methicillin-resistant Staphylococcus aureus, Commonly Encountered Scenarios when Antibiotic Use May Not Be Needed, and Concluding Remarks on Rational Use of Antibiotics in Dermatology.

Authors:  James Q Del Rosso; Ted Rosen; Diane Thiboutot; Guy F Webster; Richard L Gallo; James J Leyden; Clay Walker; George Zhanel; Lawrence Eichenfield
Journal:  J Clin Aesthet Dermatol       Date:  2016-06-01

Review 6.  Needs assessment for Mohs micrographic surgery.

Authors:  Maryam M Asgari; Jonathan M Olson; Murad Alam
Journal:  Dermatol Clin       Date:  2012-01       Impact factor: 3.478

7.  Antibiotic utilization in Medicare beneficiaries receiving Mohs micrographic surgery.

Authors:  Partik Singh; Arash Mostaghimi; John S Barbieri
Journal:  J Am Acad Dermatol       Date:  2020-02-14       Impact factor: 11.527

Review 8.  Antimicrobial prophylaxis in adults.

Authors:  Mark J Enzler; Elie Berbari; Douglas R Osmon
Journal:  Mayo Clin Proc       Date:  2011-07       Impact factor: 7.616

9.  Use of Antibiotics for Dermatologic Procedures From 2008 to 2016.

Authors:  John S Barbieri; Jeremy R Etzkorn; David J Margolis
Journal:  JAMA Dermatol       Date:  2019-04-01       Impact factor: 10.282

10.  Trends in Oral Antibiotic Prescription in Dermatology, 2008 to 2016.

Authors:  John S Barbieri; Ketaki Bhate; Kathleen P Hartnett; Katherine E Fleming-Dutra; David J Margolis
Journal:  JAMA Dermatol       Date:  2019-03-01       Impact factor: 10.282

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.